查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016048

分子细胞遗传学市场报告：按产品类型、技术、应用、最终用户和地区划分（2026-2034 年）

Molecular Cytogenetics Market Report by Product Type, Technology (Comparative Genomic Hybridization, Fluorescence in SITU Hybridization, Immunohistochemistry, Karyotyping, and Others), Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2025年全球分子细胞遗传学市场规模达32亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到66亿美元，2026年至2034年的复合年增长率为8.28%。

分子细胞遗传学是指利用去氧核糖核酸（DNA）机制研究基因突变和疾病的生物医学学科。尤其在医学和癌症相关遗传学领域，它研究染色体及其细胞核的结构和功能组织，以及基因组的变异、表达、进化和异常。 DNA扩增、DNA萃取、基因筛检、虚拟核型分析和萤光杂合反应（FISH）等技术常用于分子细胞遗传学中，利用DNA探针可视化和标记基因组或其标靶区域。这些技术对各种恶性肿瘤和骨髓恶性肿瘤的诊断和治疗极为有益。

癌症和其他遗传性疾病的日益普遍，以及老年人口的成长，是推动市场成长的关键因素。分子细胞遗传学主要用于建构疾病特征的预测模型和製定有效的治疗策略。此外，标靶治疗在癌症治疗中的广泛应用也促进了市场成长。萤光原位杂交（FISH）和比较基因组杂合反应（CGH）技术也被应用于药物基因体学和生物标记研究，以分析癌症进展并为患者提供个人化治疗。此外，耗材、试剂、软体和试剂盒等各种技术的进步也推动了市场成长。这些进步有助于获得高度可重复、准确且可靠的临床病理检测结果。医疗基础设施的显着改善以及生物医学领域广泛的研发活动等其他因素，预计也将进一步推动市场扩张。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球分子与细胞遗传学市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品类型划分

  • 装置
  • 消耗品
  • 软体和服务
  • 其他的

第七章 市场区隔：依技术划分

  • 比较基因杂合反应
  • 萤光原位杂合反应（FISH）
  • 免疫组织化学
  • 核型分析
  • 其他的

第八章 市场区隔：依应用领域划分

  • 遗传性疾病
  • 肿瘤学
  • 个人化医疗
  • 其他的

第九章 市场区隔：依最终用户划分

  • 临床和研究检查室
  • 医院和病理检查室
  • 製药和生物技术公司
  • 其他的

第十章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十一章 SWOT 分析

第十二章：价值链分析

第十三章：波特五力分析

第十四章：价格分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Applied Spectral Imaging Inc.
    • Biological Industries
    • Bio-RAD Laboratories Inc.
    • BioView Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Oxford Gene Technology
    • Perkinelmer Inc.
    • Quest Diagnostics Incorporated
Product Code: SR112026A2623

The global molecular cytogenetics market size reached USD 3.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.6 Billion by 2034, exhibiting a growth rate (CAGR) of 8.28% during 2026-2034.

Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.

The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product type, technology, application and end user.

Breakup by Product Type:

  • Instruments
  • Consumables
  • Software and Services
  • Others

Breakup by Technology:

  • Comparative Genomic Hybridization
  • Fluorescence in SITU Hybridization (FISH)
  • Immunohistochemistry
  • Karyotyping
  • Others

Breakup by Application:

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Others

Breakup by End User:

  • Clinical and Research Laboratories
  • Hospitals and Pathology Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

Key Questions Answered in This Report

1. What was the size of the global molecular cytogenetics market in 2025?

2. What is the expected growth rate of the global molecular cytogenetics market during 2026-2034?

3. What has been the impact of COVID-19 on the global molecular cytogenetics market?

4. What are the key factors driving the global molecular cytogenetics market?

5. What is the breakup of the global molecular cytogenetics market based on the product type?

6. What is the breakup of the global molecular cytogenetics market based on the technology?

7. What is the breakup of the global molecular cytogenetics market based on application?

8. What is the breakup of the global molecular cytogenetics market based on the end user?

9. What are the key regions in the global molecular cytogenetics market?

10. Who are the key players/companies in the global molecular cytogenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Cytogenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Comparative Genomic Hybridization
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fluorescence in SITU Hybridization (FISH)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunohistochemistry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Karyotyping
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Genetic Disorders
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Personalized Medicine
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Clinical and Research Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Pathology Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Applied Spectral Imaging Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Biological Industries
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 BioView Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Oxford Gene Technology
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Perkinelmer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials

List of Figures

  • Figure 1: Global: Molecular Cytogenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
  • Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
  • Figure 93: Global: Molecular Cytogenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Cytogenetics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Molecular Cytogenetics Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Molecular Cytogenetics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Molecular Cytogenetics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Molecular Cytogenetics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Molecular Cytogenetics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Molecular Cytogenetics Market Structure
  • Table 8: Global: Molecular Cytogenetics Market: Key Players